MX361273B - Metodo para obtener una vacuna de mycoplasma. - Google Patents

Metodo para obtener una vacuna de mycoplasma.

Info

Publication number
MX361273B
MX361273B MX2015007730A MX2015007730A MX361273B MX 361273 B MX361273 B MX 361273B MX 2015007730 A MX2015007730 A MX 2015007730A MX 2015007730 A MX2015007730 A MX 2015007730A MX 361273 B MX361273 B MX 361273B
Authority
MX
Mexico
Prior art keywords
subject
immunogenic composition
mycoplasma
making
relates
Prior art date
Application number
MX2015007730A
Other languages
English (en)
Other versions
MX2015007730A (es
Inventor
V Iyer Arun
M Murphy Jordan Dianna
Thomas Martinson Brian
Margaret Muehlenthaler Christine
Neubauer Axel
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49917778&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX361273(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of MX2015007730A publication Critical patent/MX2015007730A/es
Publication of MX361273B publication Critical patent/MX361273B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/70—Non-animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Developmental Biology & Embryology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a un método para producir una composición inmunogénica para el tratamiento y/o la profilaxis de infecciones por micoplasmas en un sujeto, el método está caracterizado porque comprende los pasos de: a. cultivar bacterias de Mycoplasma en un sistema de células eucarióticas con una cantidad reducida de suero, en donde dicho sistema de células eucarióticas comprende una línea de Mc Coy o una línea celular de MDCK; b. obtener un antígeno de las bacterias de Mycoplasma.
MX2015007730A 2012-12-28 2013-12-20 Metodo para obtener una vacuna de mycoplasma. MX361273B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261746997P 2012-12-28 2012-12-28
PCT/US2013/076807 WO2014105672A1 (en) 2012-12-28 2013-12-20 Method of making a mycoplasma vaccine

Publications (2)

Publication Number Publication Date
MX2015007730A MX2015007730A (es) 2015-09-07
MX361273B true MX361273B (es) 2018-12-03

Family

ID=49917778

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007730A MX361273B (es) 2012-12-28 2013-12-20 Metodo para obtener una vacuna de mycoplasma.

Country Status (23)

Country Link
US (2) US9273281B2 (es)
EP (1) EP2938747B1 (es)
JP (2) JP6122146B2 (es)
KR (1) KR102153275B1 (es)
CN (2) CN104968365B (es)
AR (1) AR094648A1 (es)
AU (1) AU2013370983B2 (es)
BR (1) BR112015012711B1 (es)
CA (1) CA2896298C (es)
CL (1) CL2015001562A1 (es)
DK (1) DK2938747T3 (es)
EA (1) EA032772B1 (es)
ES (1) ES2738100T3 (es)
HU (1) HUE045015T2 (es)
MX (1) MX361273B (es)
MY (1) MY173223A (es)
PH (1) PH12015501333A1 (es)
PL (1) PL2938747T3 (es)
PT (1) PT2938747T (es)
SG (2) SG10201708028VA (es)
TW (2) TWI660736B (es)
UA (1) UA121193C2 (es)
WO (1) WO2014105672A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
PT2938747T (pt) 2012-12-28 2019-08-01 Boehringer Ingelheim Vetmedica Gmbh Método de preparação de uma vacina de micoplasma
UA121097C2 (uk) * 2012-12-28 2020-04-10 Бьорінгер Інгельхайм Ветмедіка Гмбх Імуногенна композиція, що містить антигени мікоплазм
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
US10222383B2 (en) 2016-01-29 2019-03-05 Advanced Animal Diagnostics, Inc. Methods and compositions for detecting mycoplasma exposure
EP3498728A4 (en) * 2016-08-09 2020-03-25 Agricultural Technology Research Institute COMPOSITION FOR THE PREVENTION AND TREATMENT OF MYCOPLASMA HYORHINIS
WO2018144909A1 (en) * 2017-02-03 2018-08-09 The Administrators Of The Tulane Educational Fund Ophthalmic compositions for therapeutic and prophylactic uses
EP3632982A4 (en) 2017-05-24 2020-04-08 Mitsubishi Chemical Corporation MOLDING MATERIAL, AND FIBER REINFORCED COMPOSITE MATERIAL
EP3980523A1 (en) 2019-06-10 2022-04-13 Elanco Us Inc. Mycoplasma media formulations
CN113201050B (zh) * 2020-08-06 2022-07-22 青岛诺安百特生物技术有限公司 一种金黄色葡萄球菌噬菌体穿孔素及其制备方法和应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
GB1074920A (en) * 1965-04-21 1967-07-05 Pfizer & Co C Growth medium for mycoplasma pneumoniae and vaccine production
GB1137306A (en) 1966-07-11 1968-12-18 Research Corp Inoculum for poultry
JPS5540568B2 (es) * 1972-10-05 1980-10-18
US5338543A (en) 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
WO2001064846A1 (en) * 2000-03-03 2001-09-07 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
JP3402304B2 (ja) * 2000-03-30 2003-05-06 株式会社微生物化学研究所 猫クラミジアワクチンの製造方法
US7018638B2 (en) 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
US20030147914A1 (en) 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
PT2842569T (pt) 2001-07-02 2019-06-17 Zoetis Services Llc Vacinação de dose única com mycoplasma hyopneumoniae
EP1521592A2 (en) 2001-07-02 2005-04-13 Pfizer Products Inc. Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
JP2005500845A (ja) 2001-08-28 2005-01-13 ファイザー・プロダクツ・インク マイコプラズマ・ボビスチャレンジモデル並びにマイコプラズマ・ボビスの投与方法及び肺炎性肺病変の誘発方法
TWI238721B (en) * 2003-06-20 2005-09-01 Animal Technology Inst Taiwan Swine enzootic vaccine, its producing method and usage
JP2008529827A (ja) 2005-02-09 2008-08-07 マグナ インターナショナル インコーポレイテッド 半構造的パネルの製造方法
EP1862537B1 (en) * 2005-03-10 2013-05-08 Kyoritsu Seiyaku Corporation Cell line culturable without aminal-derived component, method for establishment thereof, method for production of virus using the cell line and method for production of vaccine
EP1934598B1 (en) * 2005-10-14 2010-09-22 Ivan Mikhailovich Petyaev Diagnosis of obligate intracellular pathogens
RU2487935C2 (ru) 2006-09-15 2013-07-20 Медиммун, Ллк. Линии клеток почки собаки майдин-дэрби (mdck), поддерживающие рост вирусов до высоких титров, и способ применения этих клеток в биореакторе
US20090068231A1 (en) 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
UY31437A1 (es) 2007-10-29 2009-05-29 Vacuna de mycoplasma bovis y métodos de uso de la misma
UA98812C2 (ru) * 2007-11-06 2012-06-25 Вайет Ллк Авирулентная активированная живая вакцина mycoplasma hyopneumoniae
WO2009126356A2 (en) 2008-01-23 2009-10-15 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
US8444989B1 (en) 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
JPWO2009142086A1 (ja) 2008-05-23 2011-09-29 学校法人 久留米大学 マイコプラズマ感染症用ワクチン組成物
JP5659332B2 (ja) 2008-06-27 2015-01-28 ゾエティス・エルエルシー 新規なアジュバント組成物
AU2009309041B2 (en) 2008-10-31 2016-02-04 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
ES2579935T3 (es) 2009-05-19 2016-08-17 Bioproperties Pty Ltd Cepa de vacuna de Mycoplasma Hyopneumoniae sensible a temperatura y uso de la misma
WO2011075379A1 (en) 2009-12-18 2011-06-23 Boehringer Ingelheim Vetmedica, Inc. Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine
US8112663B2 (en) 2010-03-26 2012-02-07 Lsi Corporation Method to establish redundancy and fault tolerance better than RAID level 6 without using parity
CN102258776B (zh) 2011-07-07 2013-07-10 普莱柯生物工程股份有限公司 猪肺炎支原体、猪鼻支原体二联灭活疫苗及其制备方法
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA121097C2 (uk) 2012-12-28 2020-04-10 Бьорінгер Інгельхайм Ветмедіка Гмбх Імуногенна композиція, що містить антигени мікоплазм
PT2938747T (pt) * 2012-12-28 2019-08-01 Boehringer Ingelheim Vetmedica Gmbh Método de preparação de uma vacina de micoplasma

Also Published As

Publication number Publication date
JP2017145253A (ja) 2017-08-24
PT2938747T (pt) 2019-08-01
BR112015012711B1 (pt) 2022-08-16
UA121193C2 (uk) 2020-04-27
TWI618542B (zh) 2018-03-21
US20160136254A1 (en) 2016-05-19
AU2013370983B2 (en) 2019-09-26
MX2015007730A (es) 2015-09-07
EA032772B1 (ru) 2019-07-31
CL2015001562A1 (es) 2016-06-24
HUE045015T2 (hu) 2019-11-28
MY173223A (en) 2020-01-07
PH12015501333A1 (en) 2015-09-02
SG10201708028VA (en) 2017-10-30
US9273281B2 (en) 2016-03-01
CA2896298C (en) 2024-01-16
EA201500701A1 (ru) 2015-12-30
BR112015012711A2 (pt) 2017-07-11
CA2896298A1 (en) 2014-07-03
EP2938747A1 (en) 2015-11-04
PL2938747T3 (pl) 2019-11-29
TW201832777A (zh) 2018-09-16
JP2016508983A (ja) 2016-03-24
US20140186394A1 (en) 2014-07-03
JP6449364B2 (ja) 2019-01-09
ES2738100T3 (es) 2020-01-20
AU2013370983A1 (en) 2015-05-21
US10512680B2 (en) 2019-12-24
JP6122146B2 (ja) 2017-04-26
CN104968365B (zh) 2018-04-03
WO2014105672A1 (en) 2014-07-03
KR20150100920A (ko) 2015-09-02
CN104968365A (zh) 2015-10-07
CN108379571A (zh) 2018-08-10
DK2938747T3 (da) 2019-08-05
TWI660736B (zh) 2019-06-01
SG11201505089YA (en) 2015-07-30
EP2938747B1 (en) 2019-05-01
AR094648A1 (es) 2015-08-19
KR102153275B1 (ko) 2020-09-09
TW201438732A (zh) 2014-10-16

Similar Documents

Publication Publication Date Title
PH12015501333A1 (en) Method of making a mycoplasma vaccine
NZ709260A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
CY1116835T1 (el) Νεο ευρωπαϊκο στελεχος toy prrsv
MX2016003419A (es) Metodos y composiciones para sindrome respiratorio coronavirus de oriente medio (mers-cov) inmunogenico.
GB201101665D0 (en) Immunogenic compositions
MX349119B (es) Vacuna de virus de dengue inactivado.
SG10201804817TA (en) Delayed release compositions of linaclotide
GEP201706668B (en) Parenteral norovirus vaccine formulations
NZ630831A (en) Compositions and methods for administration of vaccines against dengue virus
IN2013MU00711A (es)
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
PH12015501716B1 (en) Anti-mycoplasma spp. subunit vaccine
PH12015501335A1 (en) Immunogenic composition comprising mycoplasma antigens
MX364946B (es) Sistema adyuvante mejorado para la administración de vacunas orales.
EA201491845A1 (ru) Получение стерильных активных фармацевтических ингредиентов
MX363044B (es) Vacuna de virus de schmallenberg (sbv), metodos de produccion y sus usos.
TN2015000095A1 (en) Macrolide derivatives, preparation thereof and therapeutic use thereof
IN2011CH03893A (es)
IN2013CH04314A (es)
WO2014055941A3 (en) Compounds and methods for targeted immune system delivery
MX368393B (es) Preparacion de vacunas vivas.
UA69975U (ru) Способ коррекции показателей клеточного звена иммунитета у больных неалкогольным стеатогепатитом
IN2013MU01944A (es)
IN2013MU02059A (es)
UA69683U (ru) Способ лечения больных стеатогепатитом

Legal Events

Date Code Title Description
FG Grant or registration